Greater Manchester Mental Health NHS Foundation Trust
21
1
2
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.8%
1 terminated/withdrawn out of 21 trials
91.7%
+5.2% vs industry average
5%
1 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
The Mouth Matters in Mental Health Trial -2
Role: collaborator
Enhancing Child and Adolescent Mental Health Service Referrals 2
Role: lead
REAl World Dementia OUTcomes: Observational Study
Role: collaborator
A Compassionate-focused Intervention for Older People with Bipolar Disorder
Role: collaborator
Cognitive Rehabilitation for People With Cognitive Covid19
Role: collaborator
Youth Metacognitive Therapy Feasibility Trial
Role: collaborator
Cardiac Rehabilitation for Young People
Role: lead
The Mental Imagery for Suicidality in Students Trial (MISST)
Role: lead
Enhancing Referrals to Child and Adolescent Mental Health Services: EnCAMHS
Role: lead
Extended-release Pharmacotherapy for Opioid Use Disorder
Role: collaborator
Pilot of a New Cognitive Assessment Tool for Detecting Dementia in the Migrant Somali Population
Role: lead
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Role: collaborator
Cognitive AppRoaches to coMbatting Suicidality
Role: collaborator
Pathway Study WS3 - Home Based Metacognitive Therapy for Cardiac Rehabilitation Patients
Role: collaborator
A Self-Help Metacognitive Therapy for Cardiac Rehabilitation Patients (PATHWAY WS3)
Role: collaborator
i-Minds Professional Stakeholders Qualitative Study
Role: collaborator
Attachment-focused iMAgery Therapy for PSychosis (A-iMAPS)
Role: collaborator
Group-based Metacognitive Therapy for Burns and Plastics Patients
Role: collaborator
Cognitive Behaviour Therapy for Voices and Dissociation
Role: lead
Male Suicide and Metacognition
Role: lead